Supernus Pharmaceuticals | SUPN - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Abbott USD 2.39B 27M 2026-03
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Novo Nordisk DKK 33.8B 3.23B 2025-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
United Therapeutics USD 444M 6M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12